Cargando…
Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs
Nanoformulated drugs can improve pharmacodynamics and bioavailability while serving also to reduce drug toxicities for antiretroviral (ART) medicines. To this end, our laboratory has applied the principles of nanomedicine to simplify ART regimens and as such reduce toxicities while improving complia...
Autores principales: | Balkundi, Shantanu, Nowacek, Ari S., Roy, Upal, Martinez-Skinner, Andrea, McMillan, JoEllyn, Gendelman, Howard E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
MyJove Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3052269/ https://www.ncbi.nlm.nih.gov/pubmed/21178968 http://dx.doi.org/10.3791/2460 |
Ejemplares similares
-
Comparative manufacture and cell-based delivery of antiretroviral nanoformulations
por: Balkundi, Shantanu, et al.
Publicado: (2011) -
Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells
por: Kanmogne, Georgette D, et al.
Publicado: (2012) -
Opposing regulation of endolysosomal pathways by long-acting nanoformulated antiretroviral therapy and HIV-1 in human macrophages
por: Araínga, Mariluz, et al.
Publicado: (2015) -
Cellular Responses and Tissue Depots for Nanoformulated Antiretroviral Therapy
por: Martinez-Skinner, Andrea L., et al.
Publicado: (2015) -
Nanoformulated Antiretroviral Therapy Attenuates Brain Metabolic Oxidative Stress
por: Montenegro-Burke, J. Rafael, et al.
Publicado: (2018)